Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines

BACKGROUND: Among the epigenetic alterations occurring in cancer, DNA hypermethylation and histone hypoacetylation are the focus of intense research because their pharmacological inhibition has shown to produce antineoplastic activity in a variety of experimental models. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavez-Blanco, Alma, Perez-Plasencia, Carlos, Perez-Cardenas, Enrique, Carrasco-Legleu, Claudia, Rangel-Lopez, Edgar, Segura-Pacheco, Blanca, Taja-Chayeb, Lucia, Trejo-Becerril, Catalina, Gonzalez-Fierro, Aurora, Candelaria, Myrna, Cabrera, Gustavo, Duenas-Gonzalez, Alfonso
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1408081/
https://www.ncbi.nlm.nih.gov/pubmed/16448574
http://dx.doi.org/10.1186/1475-2867-6-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1408081/
https://www.ncbi.nlm.nih.gov/pubmed/16448574
http://dx.doi.org/10.1186/1475-2867-6-2

Ejemplares similares